Elevated creatine kinase activity in primary hepatocellular carcinoma

<p>Abstract</p> <p>Background</p> <p>Inconsistent findings have been reported on the occurrence and relevance of creatine kinase (CK) isoenzymes in mammalian liver cells. Part of this confusion might be due to induction of CK expression during metabolic and energetic st...

Full description

Bibliographic Details
Main Authors: Margreiter Raimund, Gellerich Frank N, Meffert Georg, Wyss Markus
Format: Article
Language:English
Published: BMC 2005-03-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/5/9
id doaj-aea96e2073044a25b07a829b252e7392
record_format Article
spelling doaj-aea96e2073044a25b07a829b252e73922020-11-25T03:55:12ZengBMCBMC Gastroenterology1471-230X2005-03-0151910.1186/1471-230X-5-9Elevated creatine kinase activity in primary hepatocellular carcinomaMargreiter RaimundGellerich Frank NMeffert GeorgWyss Markus<p>Abstract</p> <p>Background</p> <p>Inconsistent findings have been reported on the occurrence and relevance of creatine kinase (CK) isoenzymes in mammalian liver cells. Part of this confusion might be due to induction of CK expression during metabolic and energetic stress.</p> <p>Methods</p> <p>The specific activities and isoenzyme patterns of CK and adenylate kinase (AdK) were analysed in pathological liver tissue of patients undergoing orthotopic liver transplantation.</p> <p>Results</p> <p>The brain-type, cytosolic BB-CK isoenzyme was detected in all liver specimens analysed. Conversely, CK activity was strongly increased and a mitochondrial CK (Mi-CK) isoenzyme was detected only in tissue samples of two primary hepatocellular carcinomas (HCCs).</p> <p>Conclusion</p> <p>The findings do not support significant expression of CK in normal liver and most liver pathologies. Instead, many of the previous misconceptions in this field can be explained by interference from AdK isoenzymes. Moreover, the data suggest a possible interplay between p53 mutations, HCC, CK expression, and the growth-inhibitory effects of cyclocreatine in HCC. These results, if confirmed, could provide important hints at improved therapies and cures for HCC.</p> http://www.biomedcentral.com/1471-230X/5/9
collection DOAJ
language English
format Article
sources DOAJ
author Margreiter Raimund
Gellerich Frank N
Meffert Georg
Wyss Markus
spellingShingle Margreiter Raimund
Gellerich Frank N
Meffert Georg
Wyss Markus
Elevated creatine kinase activity in primary hepatocellular carcinoma
BMC Gastroenterology
author_facet Margreiter Raimund
Gellerich Frank N
Meffert Georg
Wyss Markus
author_sort Margreiter Raimund
title Elevated creatine kinase activity in primary hepatocellular carcinoma
title_short Elevated creatine kinase activity in primary hepatocellular carcinoma
title_full Elevated creatine kinase activity in primary hepatocellular carcinoma
title_fullStr Elevated creatine kinase activity in primary hepatocellular carcinoma
title_full_unstemmed Elevated creatine kinase activity in primary hepatocellular carcinoma
title_sort elevated creatine kinase activity in primary hepatocellular carcinoma
publisher BMC
series BMC Gastroenterology
issn 1471-230X
publishDate 2005-03-01
description <p>Abstract</p> <p>Background</p> <p>Inconsistent findings have been reported on the occurrence and relevance of creatine kinase (CK) isoenzymes in mammalian liver cells. Part of this confusion might be due to induction of CK expression during metabolic and energetic stress.</p> <p>Methods</p> <p>The specific activities and isoenzyme patterns of CK and adenylate kinase (AdK) were analysed in pathological liver tissue of patients undergoing orthotopic liver transplantation.</p> <p>Results</p> <p>The brain-type, cytosolic BB-CK isoenzyme was detected in all liver specimens analysed. Conversely, CK activity was strongly increased and a mitochondrial CK (Mi-CK) isoenzyme was detected only in tissue samples of two primary hepatocellular carcinomas (HCCs).</p> <p>Conclusion</p> <p>The findings do not support significant expression of CK in normal liver and most liver pathologies. Instead, many of the previous misconceptions in this field can be explained by interference from AdK isoenzymes. Moreover, the data suggest a possible interplay between p53 mutations, HCC, CK expression, and the growth-inhibitory effects of cyclocreatine in HCC. These results, if confirmed, could provide important hints at improved therapies and cures for HCC.</p>
url http://www.biomedcentral.com/1471-230X/5/9
work_keys_str_mv AT margreiterraimund elevatedcreatinekinaseactivityinprimaryhepatocellularcarcinoma
AT gellerichfrankn elevatedcreatinekinaseactivityinprimaryhepatocellularcarcinoma
AT meffertgeorg elevatedcreatinekinaseactivityinprimaryhepatocellularcarcinoma
AT wyssmarkus elevatedcreatinekinaseactivityinprimaryhepatocellularcarcinoma
_version_ 1724470062840020992